CKD-828 Telmisartan Non-Responder Trial

Mise à jour : Il y a 4 ans
Référence : NCT01426100

Femme et Homme

Extrait

The aim of the present study is to evaluate the efficacy and safety of two dose combination of Telmisartan/S-Amlodipine (40/2.5mg and 40/5mg) compared with telmisartan monotherapy (80mg) in hypertensive patients inadequately controlled by telmisartan monotherapy.


Critère d'inclusion

  • Hypertension

Liens